CHANGES IN ENDOMETRIAL CANCER CLINICAL AND MORPHOLOGICAL FEATURES DURING THE PAST HALF CENTURY

ORIGINAL ARTICLES. A. PROTOCOLS OF CLINICAL RESEARCH

https://doi.org/10.37469/0507-3758-2017-63-3-428-434

Published 01.03.2017

Lev Bershteyn⁺⁻
Igor Berlev⁺⁻
Yelena Turkevich⁺⁻
A. Baltrukova⁺⁻

Lev Bershteyn

N.N. Petrov Research Institute of Oncology

Igor Berlev

N.N. Petrov Research Institute of Oncology, I.I. Mecnikov North-West State Medical University

Yelena Turkevich

N.N. Petrov Research Institute of Oncology

A. Baltrukova

N.N. Petrov Research Institute of Oncology, I.I. Mecnikov North-West State Medical University

##article.numberofdownloads## 19

##article.numberofviews## 123

PDF (Русский)

Keywords

ENDOMETRIAL CANCER
TUMOR GROWTH
MORPHOLOGICAL CHANGES
ЭКСПРЕССИЯ PTEN И HER2/NEU
PTEN AND HER2/NEU EXPRESSION

How to Cite

Bershteyn, L., Berlev, I., Turkevich, Y., & Baltrukova, A. (2017). CHANGES IN ENDOMETRIAL CANCER CLINICAL AND MORPHOLOGICAL FEATURES DURING THE PAST HALF CENTURY. Voprosy Onkologii, 63(3), 428–434. https://doi.org/10.37469/0507-3758-2017-63-3-428-434

Abstract

Objective of the study was to compare the characteristics of endometrial cancer (EC) in patients observed in years 1965 - 1969, 1995 - 1999 and 2012 - 2015.

Results. The research was conducted on the basis of the same institution and it showed that over the past 50 years (1965 to 2015) an increase in the average age of women with primary EC. Despite the increase by through the decades in relatively favorable endometrial adenocarcinomas in relation to non-endometrioid tumors, with the increasing age of patients the incidence of non-endometrioid carcinomas increased especially due to women older than 60 years compared with patients younger than 50 years. This was reflected in such characteristics as stage of the process (according to FIGO), degree of tumor differentiation, proportion of serous carcinomas and expression of HER-2/neu.

Conclusion. Taken into account contemporary renewal of molecular-biological classification of endometrial cancer types the data collected in this study may also have practical value in particular for decisions related to personalized conservative therapy options.

https://doi.org/10.37469/0507-3758-2017-63-3-428-434

##article.numberofdownloads## 19

##article.numberofviews## 123

PDF (Русский)

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Most read articles by the same author(s)

Igor Berlev, Yekaterina Nekrasova, Gayk Mkrtchyan, Yevgeniya Bezhanova, Katran Guseynov, Yelena Ulrikh, Viktoriya Bashlyk, Anna Artemeva, Tatyana Semiglazova, Aleksandra Kondakova, Andrey Mishchenko, Nikolay Mikaya, Adiliya Urmancheeva, Nikolay Bondarev, O. Smirnova, DOSE-INTENSIVE NEOADJUVANT CHEMOTHERAPY IN COMBINED TREATMENT FOR LOCALLY ADVANCED CERVICAL CANCER: THE EXPERIENCE AND PERSPECTIVES , Voprosy onkologii : Vol. 63 No. 4 (2017)
Olga Lavrinovich, Mariia Iakovleva, Igor Berlev, Adel Urmancheeva, Fertility preservation surgeries and reproductive technologies in patients with early ovarian cancer and borderline tumors , Voprosy onkologii : Vol. 67 No. 4 (2021)
Yevgeniy Imyanitov, Aleksey Belyaev, Aleksandr Shcherbakov, Lev Bershteyn, Aleksandr Bessonov, Petr Krivorotko, Tatyana Gorodnova, Khristina Kotiv, Igor Berlev, Anna Sokolenko, Vladimir Semiglazov, PRESENCE OF BRCA1 AND BRCA2 IN HEALTHY WOMEN AND MEN: DNA TESTING, DIAGNOSTIC ACTIVITIES AND CANCER PREVENTION , Voprosy onkologii : Vol. 63 No. 2 (2017)
Irina Kovalenko, Vladimir Semiglazov, Lev Bershteyn, Garik Dashyan, Tatyana Semiglazova, Roman Kamyshinskiy, Yevgeniya Tsyrlina, Tatyana Shtam, Roman Samsonov, Anastasiya Malek, EXOSOMAL MICRO-RNA - POTENTIAL PREDICTIVE MARKER OF BREAST CANCER NEOADJUVANT THERAPY EFFECT , Voprosy onkologii : Vol. 64 No. 6 (2018)
Tatyana Gorodnova, Igor Berlev, Adiliya Urmancheeva, Yelena Bakhidze, Andrey Domanskiy, Nikolay Mikaya, Inna Amelina, Irina Meshkova, Olga Lavrinovich, Yelena Ulrikh, Anna Sidoruk, Yekaterina Nekrasova, Olga Smirnova, Zaur Ibragimov, Khristina Kotiv, Nikolay Bondarev, Katran Guseynov, N. Matveeva, ROLE OF LYMPHADENECTOMY IN TREATMENT FOR EPITHELIAL OVARIAN CANCER , Voprosy onkologii : Vol. 64 No. 1 (2018)
Елена Ульрих, Gulfiya Teletaeva, Anna Semenova, Evgenii Levchenko, Dariya Ulrikh, Igor Berlev, Tatyana Semiglazova, Svetlana Protsenko, Adel Urmancheeva, Individualization in the treatment of resistant forms of gestational trophoblastic neoplasia , Voprosy onkologii : Vol. 66 No. 6 (2020)
Aglaya Iyevleva, Tatiana Gorodnova, Svetlana Aleksakhina, Elena Anisimova, Larisa Gigolaeva, Anna Sokolenko, Kirill Zagorodnev, Vadim Dmitriev, Igor Berlev, Piotr Krivorotko, Evgeny Imyanitov, Detection of TP53 mutations in plasma of ovarian cancer and breast cancer patients , Voprosy onkologii : Vol. 67 No. 2 (2021)
Lev Bershteyn, Tatyana Poroshina, Zamira Radzhabova, Irina Kovalenko, Aleksandr Ivantsov, Aglaya Ievleva, Igor Berlev, COMPARATIVE FEATURES OF CARBOHYDRATE METABOLISM STATE, BODY WEIGHT AND ASSOCIATED HORMONAL FACTORS IN VARIOUS MOLECULAR-BIOLOGICAL TYPES OF ENDOMETRIAL CANCER , Voprosy onkologii : Vol. 64 No. 3 (2018)
Lev Bershteyn, Aglaya Ievleva, Aleksandr Ivantsov, D. Vasiliev, Maksim Kleshchev, Tatyana Poroshina, Irina Kovalenko, A. Venina, I. Berlev, MODERN MOLECULAR BIOLOGICAL TYPES OF ENDOMETRIAL CANCER: COMPARATIVE ENDOCRINE AND PROINFLAMMATORY-PROGENOTOXIC CHARACTERISTICS , Voprosy onkologii : Vol. 65 No. 2 (2019)
Tatyana Gorodnova, N. Matveeva, Yevgeniy Imyanitov, Igor Berlev, Adiliya Urmancheeva, Nikolay Mikaya, Anna Sidoruk, Yekaterina Nekrasova, Irina Meshkova, Yelena Ulrikh, Katran Guseynov, Khristina Kotiv, Yekaterina Kuligina, Anna Sokolenko, Yu. Trifanov, FEATURES OF RECURRENCE OF BCRA-POSITIVE OVARIAN CANCER , Voprosy onkologii : Vol. 63 No. 2 (2017)

<< < 1 2 3 > >>